Contouring for Genitourinary Cancer
This activity will evaluate contouring principles for patients with genitourinary malignancies and includes discussion about prostate cancers (definitive and post-operative) and bladder cancer.
The content was originally presented and recorded at the 2026 ASTRO Annual Refresher Course
This activity includes a didactic background lecture and case/contour review. It does not include the hands-on practice cases.
This activity is available from June 11, 2026, through July 8, 2028.
Target Audience
This course is designed to meet the interest of radiation oncologists and radiation oncology residents.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Evaluate CTV delineations for prostate (definitive and post-operative), kidney, and bladder cancers.
- Discuss OAR and GTV delineation for intact prostate cancer.
- Discuss motion management principles for prostate (definitive and post-operative), kidney, and bladder cancers.
Speaker
- Amar Kishan, MD, is employed by UCLA. Dr. Kishan receives Consultant role honoraria from Varian Medical Systems and Boston Scientific. Dr. Kishan receives grant/research funding (institution) from Janssen, Inc., Point BioPharma and ViewRay Systems and grant/research funding (individual) from Lantheus and Novartis. Dr. Kishan has ownership equity in MiraDx.
Planner/Moderator Disclosures
- Megan Daly, MD, is employed by University of California Davis. Dr. Daly receives grant/research funding (institution) from Genentech and honoraria from AstraZeneca. Dr. Daly received grant/research funding (institution) from Merck [relationship ended December 2025] and honoraria from Dava [relationship ended October 2024]; Novocure [relationship ended November 2024]; and Bristol Myers Squibb [relationship ended November 2024].
- Sue Yom, MD, PhD, FASTRO, is employed by University of California San Francisco. Dr. Yom receives grant/research funding (institution) from Bristol Myers Squibb, EMD Serono and Johnson & Johnson.
The person(s) above served as the developer(s) of this activity.
All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $149
- Member: $99
- Member-in-Training: $49
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until July 8, 2028, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.

Facebook
X
LinkedIn
Forward